Q-omics provides the consensus-scored MIR520B profile across patient tissues and cancer cell-line models. MIR520B expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in LGG. Additionally, MIR520B RNA expression shows 5,905 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LGG, and STAD as cancer lineages where MIR520B shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.